Skip to main content
Top

Current Treatment Options in Oncology

Issue 8/2020

Content (9 Articles)

Lymphoma Lymphoma (DO Persky, Section Editor)

Hypomethylating Agents in Lymphoma

Jacob C. Cogan, Yuxuan Liu, Jennifer E. Amengual

Cytostatic Therapy Upper Gastrointestinal Cancers (JD Berlin, Section Editor)

Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma

Satya Das, Dana Cardin

Gallbladder Cancer Upper Gastrointestinal Cancers (JD Berlin, Section Editor)

New Treatment Options for Advanced Biliary Tract Cancer

Jonathan D. Mizrahi, Rachna T. Shroff

NSCLC Lung Cancer (HA Wakelee and TA Leal, Section Editors)

Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer

Puneet Saxena, Pawan Kumar Singh, Prabhat Singh Malik, Navneet Singh

Lung Cancer Lung Cancer (HA Wakelee and TA Leal, Section Editors)

Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy

Meera Ragavan, Millie Das

giant cell tumor Sarcoma (SH Okuno, Section Editor)

Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone

Emanuela Palmerini, Eric Lodewijk Staals, Louis Baxter Jones, Davide Maria Donati, Alessandra Longhi, R. Lor Randall

osteosarcoma Sarcoma (SH Okuno, Section Editor)

Role of TKI for Metastatic Osteogenic Sarcoma

Florence Duffaud

Open Access Acute Myeloid Leukemia Leukemia (PH Wiernik, Section Editor)

Treatment of Relapsed Acute Myeloid Leukemia

Felicitas Thol, Arnold Ganser

Chronic Lymphocytic Leukemia Cardio-oncology (MG Fradley, Section Editor)

Cardiovascular Toxicities of Bruton’s Tyrosine Kinase Inhibitors

Ricardo Pineda-Gayoso, Mohammed Alomar, Dae Hyun Lee, Michael G. Fradley

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine